November 4, 2014

San Mateo, CA – Congresswomen Jackie Speier (D-San Francisco/San Mateo Counties) will tour South San Francisco based Vaxart on Wednesday, November 5, 2014 to see first-hand the company’s efforts to develop an oral Ebola vaccine.

Vaxart announced that it will revive development of an experimental vaccine that it stopped in 2012 due to low interest. The most recent outbreak of Ebola in West Africa that started in March has killed almost 5,000 people globally. No vaccines for Ebola have been approved by the U.S. Food and Drug Administration (FDA). In 2012, Vaxart was working on a vaccine that showed improved signs of immunity in mice. Vaxart recently reported that it will ask the FDA to begin early safety clinical trials in humans next year.

Speier stated, “Vaxart could hold a key to stemming the current Ebola crisis in West Africa and prevent future outbreaks. I want the federal government to take a second look at what’s going on here and to determine if an appropriate review might be of benefit to the public.”

Speier will tour Vaxart on Wednesday at 2 pm and will be available with Vaxart representatives to speak to the press at 3:45 pm at the company’s headquarters at 385 Oyster Point Blvd., South San Francisco.